Publication: Autoallergy and what the Allergist Needs to know
| dc.contributor.author | Steinert, Carolin | |
| dc.contributor.author | Pashuk, Margarita | |
| dc.contributor.author | Kolkhir, P. V. | |
| dc.contributor.author | Kocaturk Goncu, Emek Ozgur | |
| dc.contributor.author | Xiang, Yi Kui | |
| dc.contributor.institution | Steinert, Carolin, Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany, Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany, Department of Biology, Freie Universität Berlin, Berlin, Germany | |
| dc.contributor.institution | Pashuk, Margarita, Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany, Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany, Department of Biology, Freie Universität Berlin, Berlin, Germany | |
| dc.contributor.institution | Kolkhir, P. V., Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany, Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany | |
| dc.contributor.institution | Kocaturk Goncu, Emek Ozgur, Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany, Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany, Department of Dermatology, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Xiang, Yi Kui, Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany, Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany, Tongji University School of Medicine, Shanghai, China | |
| dc.date.accessioned | 2025-10-05T14:24:11Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Purpose of the Review: This review aims to educate allergists about the concept of autoallergy by addressing five questions: 1) What is autoallergy and how does it differ from classical allergy? 2) How common is autoallergy? 3) Is autoallergy clinically relevant? 4) How can autoallergy be diagnosed? and 5) How is autoallergy treated? Recent Findings: In contrast to type I hypersensitivity against external allergens (allergy), autoallergy involves IgE autoantibodies targeting self-antigens. These are found in conditions like chronic spontaneous urticaria, atopic dermatitis, and asthma, with varying prevalence. While no standardized diagnostic tools exist, ELISA and basophil activation tests help identify the presence and function of IgE autoantibodies. Anti-IgE therapies have shown benefit, supporting their clinical relevance. Summary: Autoallergy is emerging as a distinct IgE-mediated mechanism that may contribute to chronic inflammation in immune-mediated diseases. Further investigation of this mechanism can improve disease stratification and enable more effective, targeted treatment strategies. © 2025 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.1007/s11882-025-01215-8 | |
| dc.identifier.issn | 15297322 | |
| dc.identifier.issn | 15346315 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pubmed | 40782271 | |
| dc.identifier.scopus | 2-s2.0-105012976413 | |
| dc.identifier.uri | https://doi.org/10.1007/s11882-025-01215-8 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/6080 | |
| dc.identifier.volume | 25 | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.source | Current Allergy and Asthma Reports | |
| dc.subject.authorkeywords | Asthma | |
| dc.subject.authorkeywords | Atopic Dermatitis | |
| dc.subject.authorkeywords | Autoallergy | |
| dc.subject.authorkeywords | Autoantibodies | |
| dc.subject.authorkeywords | Chronic Spontaneous Urticaria | |
| dc.subject.authorkeywords | Ige | |
| dc.subject.authorkeywords | Atuzabrutinib | |
| dc.subject.authorkeywords | Barzolvolimab | |
| dc.subject.authorkeywords | Branebrutinib | |
| dc.subject.authorkeywords | Dupilumab | |
| dc.subject.authorkeywords | Fenebrutinib | |
| dc.subject.authorkeywords | Immunoglobulin E | |
| dc.subject.authorkeywords | Omalizumab | |
| dc.subject.authorkeywords | Remibrutinib | |
| dc.subject.authorkeywords | Rilzabrutinib | |
| dc.subject.authorkeywords | Allergens | |
| dc.subject.authorkeywords | Autoantibodies | |
| dc.subject.authorkeywords | Autoantigens | |
| dc.subject.authorkeywords | Immunoglobulin E | |
| dc.subject.authorkeywords | Allergen | |
| dc.subject.authorkeywords | Atuzabrutinib | |
| dc.subject.authorkeywords | Barzolvolimab | |
| dc.subject.authorkeywords | Branebrutinib | |
| dc.subject.authorkeywords | Bruton Tyrosine Kinase Inhibitor | |
| dc.subject.authorkeywords | Dupilumab | |
| dc.subject.authorkeywords | Fenebrutinib | |
| dc.subject.authorkeywords | Immunoglobulin E | |
| dc.subject.authorkeywords | Immunoglobulin E Antibody | |
| dc.subject.authorkeywords | Omalizumab | |
| dc.subject.authorkeywords | Remibrutinib | |
| dc.subject.authorkeywords | Rilzabrutinib | |
| dc.subject.authorkeywords | Autoantibody | |
| dc.subject.authorkeywords | Autoantigen | |
| dc.subject.authorkeywords | Allergic Asthma | |
| dc.subject.authorkeywords | Allergic Bronchopulmonary Aspergillosis | |
| dc.subject.authorkeywords | Allergy Test | |
| dc.subject.authorkeywords | Antibody Titer | |
| dc.subject.authorkeywords | Asthma | |
| dc.subject.authorkeywords | Atopic Dermatitis | |
| dc.subject.authorkeywords | Autoimmunity | |
| dc.subject.authorkeywords | Basophil Activation Test | |
| dc.subject.authorkeywords | Basophil Histamine Release Assay | |
| dc.subject.authorkeywords | Bullous Pemphigoid | |
| dc.subject.authorkeywords | Chronic Spontaneous Urticaria | |
| dc.subject.authorkeywords | Cross Reaction | |
| dc.subject.authorkeywords | Direct Elisa | |
| dc.subject.authorkeywords | Disease Activity | |
| dc.subject.authorkeywords | Disease Severity | |
| dc.subject.authorkeywords | Drug Efficacy | |
| dc.subject.authorkeywords | Drug Protein Binding | |
| dc.subject.authorkeywords | Drug Response | |
| dc.subject.authorkeywords | Drug Safety | |
| dc.subject.authorkeywords | Enzyme Linked Immunosorbent Assay | |
| dc.subject.authorkeywords | Food Allergy | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Immediate Type Hypersensitivity | |
| dc.subject.authorkeywords | Immunoblotting | |
| dc.subject.authorkeywords | Immunologist | |
| dc.subject.authorkeywords | Indirect Elisa | |
| dc.subject.authorkeywords | Medical Education | |
| dc.subject.authorkeywords | Microarray Analysis | |
| dc.subject.authorkeywords | Milk Allergy | |
| dc.subject.authorkeywords | Nonhuman | |
| dc.subject.authorkeywords | Pathogenesis | |
| dc.subject.authorkeywords | Pollen Allergy | |
| dc.subject.authorkeywords | Prick Test | |
| dc.subject.authorkeywords | Radioimmunoassay | |
| dc.subject.authorkeywords | Review | |
| dc.subject.authorkeywords | Sandwich Elisa | |
| dc.subject.authorkeywords | Skin Test | |
| dc.subject.authorkeywords | Western Blotting | |
| dc.subject.authorkeywords | Diagnosis | |
| dc.subject.authorkeywords | Hypersensitivity | |
| dc.subject.authorkeywords | Immunology | |
| dc.subject.authorkeywords | Therapy | |
| dc.subject.authorkeywords | Allergens | |
| dc.subject.authorkeywords | Allergists | |
| dc.subject.authorkeywords | Autoantibodies | |
| dc.subject.authorkeywords | Autoantigens | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Hypersensitivity | |
| dc.subject.authorkeywords | Immunoglobulin E | |
| dc.subject.indexkeywords | allergen | |
| dc.subject.indexkeywords | atuzabrutinib | |
| dc.subject.indexkeywords | barzolvolimab | |
| dc.subject.indexkeywords | branebrutinib | |
| dc.subject.indexkeywords | Bruton tyrosine kinase inhibitor | |
| dc.subject.indexkeywords | dupilumab | |
| dc.subject.indexkeywords | fenebrutinib | |
| dc.subject.indexkeywords | immunoglobulin E | |
| dc.subject.indexkeywords | immunoglobulin E antibody | |
| dc.subject.indexkeywords | omalizumab | |
| dc.subject.indexkeywords | remibrutinib | |
| dc.subject.indexkeywords | rilzabrutinib | |
| dc.subject.indexkeywords | autoantibody | |
| dc.subject.indexkeywords | autoantigen | |
| dc.subject.indexkeywords | allergic asthma | |
| dc.subject.indexkeywords | allergic bronchopulmonary aspergillosis | |
| dc.subject.indexkeywords | allergy test | |
| dc.subject.indexkeywords | antibody titer | |
| dc.subject.indexkeywords | asthma | |
| dc.subject.indexkeywords | atopic dermatitis | |
| dc.subject.indexkeywords | autoimmunity | |
| dc.subject.indexkeywords | basophil activation test | |
| dc.subject.indexkeywords | basophil histamine release assay | |
| dc.subject.indexkeywords | bullous pemphigoid | |
| dc.subject.indexkeywords | chronic spontaneous urticaria | |
| dc.subject.indexkeywords | cross reaction | |
| dc.subject.indexkeywords | direct ELISA | |
| dc.subject.indexkeywords | disease activity | |
| dc.subject.indexkeywords | disease severity | |
| dc.subject.indexkeywords | drug efficacy | |
| dc.subject.indexkeywords | drug protein binding | |
| dc.subject.indexkeywords | drug response | |
| dc.subject.indexkeywords | drug safety | |
| dc.subject.indexkeywords | enzyme linked immunosorbent assay | |
| dc.subject.indexkeywords | food allergy | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | immediate type hypersensitivity | |
| dc.subject.indexkeywords | immunoblotting | |
| dc.subject.indexkeywords | immunologist | |
| dc.subject.indexkeywords | indirect ELISA | |
| dc.subject.indexkeywords | medical education | |
| dc.subject.indexkeywords | microarray analysis | |
| dc.subject.indexkeywords | milk allergy | |
| dc.subject.indexkeywords | nonhuman | |
| dc.subject.indexkeywords | pathogenesis | |
| dc.subject.indexkeywords | pollen allergy | |
| dc.subject.indexkeywords | prick test | |
| dc.subject.indexkeywords | radioimmunoassay | |
| dc.subject.indexkeywords | Review | |
| dc.subject.indexkeywords | sandwich ELISA | |
| dc.subject.indexkeywords | skin test | |
| dc.subject.indexkeywords | Western blotting | |
| dc.subject.indexkeywords | diagnosis | |
| dc.subject.indexkeywords | hypersensitivity | |
| dc.subject.indexkeywords | immunology | |
| dc.subject.indexkeywords | therapy | |
| dc.subject.indexkeywords | Allergens | |
| dc.subject.indexkeywords | Allergists | |
| dc.subject.indexkeywords | Autoantibodies | |
| dc.subject.indexkeywords | Autoantigens | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Hypersensitivity | |
| dc.subject.indexkeywords | Immunoglobulin E | |
| dc.title | Autoallergy and what the Allergist Needs to know | |
| dc.type | Review | |
| dcterms.references | Svenningsen, Sarah, Asthma endotypes and an overview of targeted therapy for asthma, Frontiers in Medicine, 4, SEP, (2017), Otsuka, Atsushi, The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis, Immunological Reviews, 278, 1, pp. 246-262, (2017), Fyhrquist, Nanna, Endotypes of atopic dermatitis, Journal of Allergy and Clinical Immunology, 156, 1, pp. 24-40.e4, (2025), Zuberbier, Thorsten, The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria, Allergy: European Journal of Allergy and Clinical Immunology, 77, 3, pp. 734-766, (2022), Kolkhir, P. V., Autoimmune chronic spontaneous urticaria, Journal of Allergy and Clinical Immunology, 149, 6, pp. 1819-1831, (2022), Baker, Mary Grace, Food allergy endotypes revisited, Journal of Allergy and Clinical Immunology, 156, 1, pp. 1-16, (2025), Pawankar, Ruby U., The unmet global health need of severe and complex allergies: Meeting the challenge, World Allergy Organization Journal, 5, 2, pp. 20-21, (2012), Charles, Nicolas, Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases, Allergy: European Journal of Allergy and Clinical Immunology, 78, 12, pp. 3118-3135, (2023), Johansson, Siv Gunnar O., The discovery of IgE, Journal of Allergy and Clinical Immunology, 137, 6, pp. 1671-1673, (2016), Galli, Stephen Joseph, IgE and mast cells in allergic disease, Nature Medicine, 18, 5, pp. 693-704, (2012) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 57221965707 | |
| person.identifier.scopus-author-id | 60036309300 | |
| person.identifier.scopus-author-id | 56076677500 | |
| person.identifier.scopus-author-id | 18437291300 | |
| person.identifier.scopus-author-id | 57221958792 |
